Abstract
CD59, belonging to membrane complement regulatory proteins (mCRPs), inhibits the cytolytic activity of complement and is over-expressed in solid cancers, including ovary cancer. The aim of the present study was to construct recombinant retrovirus encoding shRNA targeted human CD59 and infect A2780 cells in order to investigate the relationship between decreased CD59 expression and tumorigenesis of ovary cancer. siCD59 and siCD59-C were successfully constructed and identified by PCR, restriction endonuclease analyses and DNA sequencing, respectively. The siCD59 was able to efficiently infect A2780 cells, which was confirmed by Western blotting. When incubated with fresh normal human serum (8%, v/v) for 1 h at 37°C, the cell viability was decreased and cell damage was increased in siCD59 infected A2780 cells compared to siCD59-C infected cells. This led to the activation of caspase-3. The apoptosis in siCD59 infected cells was shown with hypercondensed nuclei using Hoechst staining. Meanwhile, the weight of ovary tumor graft in nude mice was significantly decreased in siCD59 group compared to that of siCD59-C group. And the expression of CD59 protein in tumor tissue in siCD59 group was significantly decreased. These results suggested that CD59 silencing in ovary cancer cells via retrovirus-mediated RNAi can enhance complement-mediated cell damage, inhibiting growth of ovary cancer. CD59 might be a potential target for gene therapy in ovary cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shi, X., Zhang, B., Zang, J. et al. CD59 Silencing via Retrovirus-Mediated RNA Interference Enhanced Complement-Mediated Cell Damage in Ovary Cancer. Cell Mol Immunol 6, 61–66 (2009). https://doi.org/10.1038/cmi.2009.8
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/cmi.2009.8
Keywords
This article is cited by
-
The function of adipsin and C9 protein in the complement system in HIV-associated preeclampsia
Archives of Gynecology and Obstetrics (2021)
-
CD59 is a potential biomarker of esophageal squamous cell carcinoma radioresistance by affecting DNA repair
Cell Death & Disease (2018)
-
Application of a novel inhibitor of human CD59 for the enhancement of complement-dependent cytolysis on cancer cells
Cellular & Molecular Immunology (2011)
-
Tissue factor expression in ovarian cancer: implications for immunotherapy with hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor
Clinical & Experimental Metastasis (2011)
-
Complement in Cancer and Cancer Immunotherapy
Archivum Immunologiae et Therapiae Experimentalis (2011)